非布司他2020年价格

The main ingredient of febuxostat (febuxostat, feburic) is febuxostat, whose chemical name is 2-[(3-cyano-4-isobutoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid. As a xanthine oxidase (XO) inhibitor, Buxostat tablets are a drug used to treat ventilation, developed and authorized by Teijin Pharmaceutical of Japan. Febuxostat was launched in Europe in 2008, in the United States in 2009, and in China since 2013.

The advantages of febuxostat (febuxostat, feburic) include: 1. Allopurinol only inhibits the reduced XOR, while febuxostat (febuxostat, feburic) has a significant inhibitory effect on both oxidized and reduced XOR, so its effect of reducing uric acid is more powerful and lasting; 2. Since allopurinol is a purine analogue, it inevitably affects the activities of other enzymes involved in purine and pyridine metabolism. Therefore, repeated high-dose administration is required to maintain high drug levels during allopurinol treatment. This also leads to serious or even fatal adverse reactions due to drug accumulation. Febuxostat (febuxostat, feburic) is a non-purine XOR inhibitor and therefore has better safety. 

What is the price of Febuxostat in 2020?

The price of febuxostat (febuxostat, feburic) sold in Japan is relatively expensive, and long-term use is burdensome for most patients. Therefore, many patients turn to the cheaper febuxostat (febuxostat, feburic). Medical Companion Travel has learned that the efficacy of Febuxostat produced by Zydus Pharmaceuticals in India is the same as that of the original drug, but the price is much cheaper. The specification is 80mg*30 tablets/box. Its price is about 80$, and the specification is 40mg*100 tablets/box. The price is about 200$. Due to the floating exchange rate, the price will be different. For specific prices, please consult the regular overseas medical service company Medical Companion Travel.